» Articles » PMID: 30659636

Long Noncoding Antisense RNA FAM83A-AS1 Promotes Lung Cancer Cell Progression by Increasing FAM83A

Overview
Journal J Cell Biochem
Date 2019 Jan 20
PMID 30659636
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

The abnormal expression of long noncoding RNAs (lncRNAs) is closely associated with human cancers. As one special group of lncRNAs, natural antisense transcripts (NATs) can be transcribed from both DNA strands at the same locus but in the opposite direction from the gene transcript. Their expression levels are altered in many cancers, but their roles are poorly understood. We strove to find NATs involved in human non-small-cell lung cancer (NSCLC) and to reveal their mechanism of action in cancer. We analysed the NATs in NSCLC from the TCGA database by circlncRNAnet. One NAT, family with sequence similarity 83 member A antisense RNA 1 (FAM83A-AS1), was found to be markedly upregulated and positively correlated with its cognate sense counterpart, FAM83A, in NSCLC. Moreover, overexpression of FAM83A-AS1 increased FAM38A protein levels and induced ERK1/2 phosphorylation downstream of FAM83A in cells. Finally, overexpression of FAM83A-AS1 promoted LUAD cell proliferation and invasion. In summary, lncRNA FAM83A-AS1 promotes LUAD by increasing FAM83A expression.

Citing Articles

FAM83A-AS1 predicts severe development of non-small cell lung cancer and adverse postoperative prognosis of thoracotomy.

Tang F, Liang Y, Zhang L, Qiu L, Xu C J Cardiothorac Surg. 2025; 20(1):24.

PMID: 39757175 PMC: 11702059. DOI: 10.1186/s13019-024-03235-3.


Prognostic Indicators for Precision Treatment of Non-Small Cell Lung Carcinoma.

Ghosh D, McDonald H, Dutta R, Krishnan K, Thilakan J, Paul M Cells. 2024; 13(21.

PMID: 39513892 PMC: 11545304. DOI: 10.3390/cells13211785.


Novel insights on the positive correlation between sense and antisense pairs on gene expression.

Das S, Zea Rojas M, Tran E Wiley Interdiscip Rev RNA. 2024; 15(4):e1864.

PMID: 39087253 PMC: 11626863. DOI: 10.1002/wrna.1864.


A genomic instability-associated lncRNA signature for predicting prognosis and biomarkers in lung adenocarcinoma.

Lin C, Lin K, Li P, Yuan H, Lin X, Dai Y Sci Rep. 2024; 14(1):14460.

PMID: 38914679 PMC: 11196711. DOI: 10.1038/s41598-024-65327-3.


Identification of tumor heterogeneity associated with KRAS/TP53 co-mutation status in lung adenocarcinoma based on single-cell RNA sequencing.

Ye Y, Zhang Y, Luo Y, Xu A, Ji L Am J Cancer Res. 2024; 14(2):655-678.

PMID: 38455404 PMC: 10915312.


References
1.
McHugh B, Murdoch A, Haslett C, Sethi T . Loss of the integrin-activating transmembrane protein Fam38A (Piezo1) promotes a switch to a reduced integrin-dependent mode of cell migration. PLoS One. 2012; 7(7):e40346. PMC: 3390408. DOI: 10.1371/journal.pone.0040346. View

2.
Grant S . FAM83A and FAM83B: candidate oncogenes and TKI resistance mediators. J Clin Invest. 2012; 122(9):3048-51. PMC: 3428099. DOI: 10.1172/JCI64412. View

3.
Etem E, Ceylan G, Ozaydin S, Ceylan C, Ozercan I, Kuloglu T . The increased expression of Piezo1 and Piezo2 ion channels in human and mouse bladder carcinoma. Adv Clin Exp Med. 2018; 27(8):1025-1031. DOI: 10.17219/acem/71080. View

4.
Liao Z, Wang X, Liang H, Yu A, Ur Rehman U, Fan Q . miR-1 suppresses the proliferation and promotes the apoptosis of esophageal carcinoma cells by targeting Src. Cancer Med. 2017; 6(12):2957-2965. PMC: 5727306. DOI: 10.1002/cam4.1214. View

5.
Zhang M, Wu J, Zhong W, Zhao Z, Liu Z . Long non-coding RNA BRE-AS1 represses non-small cell lung cancer cell growth and survival via up-regulating NR4A3. Arch Biochem Biophys. 2018; 660:53-63. DOI: 10.1016/j.abb.2018.09.013. View